Updates are available Correction dated 2018-12-24
Click to view Correction: https://doi.org/10.1186/s12885-018-5215-7
-
Authors
Tan, Wan-Ling
Ng, Quan Sing
Lim, Cindy
Tan, Eng Huat
Toh, Chee Keong
Ang, Mei-Kim
Kanesvaran, Ravindran
Jain, Amit
Tan, Daniel S. W.
Lim, Darren Wan-Teck https://orcid.org/0000-0002-4655-0206
-
Funding
Funding for this research was provided by:
National Medical Research Council (Singapore) (NMRC/TCR/007-NCC/2013)
National Medical Research Council (CSA/0025/2017)
- License Information
-
More Information
Article History
Received: 30 August 2018
Accepted: 20 November 2018
First Online: 3 December 2018
Change Date: 24 December 2018
Change Type: Correction
Change Details: ᅟ
Ethics approval and consent to participate
: A written informed consent to participate was obtained from each of the patients under our Lung Cancer Consortium Singapore (LCCS) data-base. This study was approved by Centralized Institutional Review Board (CIRB), Singapore (CIRB 2007/444/B). Patient data were de-identified and anonymized before analysis.
: Not applicable.
: Dr. WT Lim reports grants from BMS, honoraria for advisory boards from MSD, Boehringer-Ingelheim, and Takeda, outside the submitted work; Dr. DSW Tan reports grants and honoraria for advisory boards and other from Novartis, Bayer, Boehringer Ingelheim, Merck, AstraZeneca, BMS, Roche and grants from GSK, outside the submitted work; Dr. QS Ng reports being in the Advisory board of Boehringer-Ingelheim. The remaining authors declare no potential conflict of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
